LabCorp (various)

3-O-Methyldopa (3-OMD) is a compound that emerges in the context of diagnosing and monitoring various medical conditions, particularly those related to neurological disorders such as Parkinson's disease. It's essential to understand that 3-OMD is closely related to L-DOPA, a medication widely used in the treatment of Parkinson's disease. In patients receiving L-DOPA therapy, 3-OMD is produced as a metabolite - a substance created during the breakdown and conversion of the drug within the body. The presence and levels of 3-O-Methyldopa in the body can be significant for several reasons. For patients undergoing treatment with L-DOPA, measuring 3-OMD levels can help in monitoring the efficacy of the treatment and in adjusting dosages to achieve optimal therapeutic effects. Elevated levels of 3-OMD might suggest that the body is metabolizing L-DOPA more into 3-OMD than is ideal, which could lead to adjustments in treatment to improve outcomes. Furthermore, understanding the levels of 3-O-Methyldopa can also contribute to the broader understanding of a patient's metabolic processes and the possible need for adjustments in therapeutic strategies. If the concentraton of 3-O-methyldopa in plasma is within the reference range, it demonstrates that the individual does not have aromatc L-amino acid decarboxylase (AADC) defciency.

To help diagnose and monitor sarcoidosis

Volatile substances in the blood include ethanol, methanol, isopropanol, and acetone. Acetone is generally elevated in metabolic conditions such as diabetic ketoacidosis. Methanol and isopropanol are highly toxic and result from exogenous ingestion. The presence of acetone may indicate exposure to acetone; it is also a metabolite of isopropanol and may be detected during ketoacidosis.

Screening test for the factor V Leiden gene mutation

The "Aluminum, Plasma/Serum" test measures the level of aluminum in your blood, specifically in the plasma or serum component. Aluminum is the third most abundant element in the Earth's crust and is commonly found in our environment, including water, food, and some consumer products. While it's generally considered non-toxic at low levels, exposure to high levels of aluminum can lead to health issues, especially in individuals with compromised kidney function or those exposed to the metal through occupational hazards, medical treatments, or excessive use of aluminum-containing products. The test is particularly important for individuals who are at risk of aluminum exposure or toxicity, such as patients undergoing dialysis, where the dialysis solution might be contaminated with aluminum, or people with occupational exposure to aluminum dust. High levels of aluminum in the plasma or serum can indicate excessive exposure or accumulation of the metal in the body, leading to potential health risks. These risks include neurotoxic effects, such as cognitive impairment and encephalopathy (a brain disease that can cause memory problems, personality changes, and impaired cognitive function), bone diseases, and anemia. For patients with kidney diseases, especially those on dialysis, monitoring aluminum levels is crucial because their kidneys cannot effectively remove aluminum from the body. In such cases, the test helps in diagnosing aluminum overload and guiding treatment to prevent its toxic effects. It's also used to monitor the effectiveness of treatments aimed at reducing aluminum levels, such as chelation therapy, a process that uses certain drugs to remove heavy metals from the body. Understanding the results of this test can help healthcare providers make informed decisions about potential sources of exposure, necessary changes in diet or environmental conditions, and appropriate medical interventions to reduce aluminum levels in the body. It's an essential tool in managing and preventing aluminum toxicity, ensuring patients, especially those at higher risk, maintain safe levels of aluminum exposure.

mainly of use in the diagnosis of urea cycle deficiencies

helps determine whether you have had a recent strep infection

a potential sign of heart damage

Anti-sarcolemma antibodies are a type of antibodies that can be found in certain medical conditions. They are specifically associated with cardiac muscle disorders and are often detected in patients with conditions such as Dressler's syndrome after myocardial infarction, cardiomyopathy, myocarditis, rheumatic fever, and those who have undergone cardiac surgery. These antibodies can target various antigens, including adenine nucleotide translocator protein, cardiac myosin, and tropomyosin. Antisarcolemmal (ASAs) are a serologic hallmark of inflammatory heart muscle disease (= Myocarditis) and its sequelae (= any complication or condition that results from a pre-existing illness, injury, or medical intervention). Myocarditis is inflammation of the heart muscle (myocardium). The inflammation can reduce the heart's ability to pump blood. Myocarditis can cause chest pain, shortness of breath, and rapid or irregular heart rhythms (arrhythmias). Background of Anti-sarcolemmal Antibody (ASA): Sarcolemmal, also sarcolemma, is the plasma membrane of the muscle cell and is surrounded by a basement membrane and endomysial connective tissue. Sarcolemma, together with an extracellular layer of carbohydrate and collagenous macromolecules which imparts some mechanical strength, is attached to the tendon or aponeurosis of origin and insertion at the end of the fiber. Sarcolemma is similar to the plasmalemma in biochemical composition, which consists of a lipid bilayer and a thin outer coat of polysaccharide material. The function of sarcolemma in muscle cells is generally the same as the plasma membrane in other eukaryote cells. Substantially, the sarcolemma is a kind of excitable membrane, shares many properties with the neuronal cell membrane and play critical actions in various biological activities. Anti-sarcolemmal antibodies (ASAs) are autoantibodies that have been observed and identified in lymphocyte-mediated cytotoxicity. The Role of Anti-sarcolemmal Antibody (ASA) in Myocarditis: Myocarditis is a kind of inflammation and damage of the heart muscle or myocardium with some symptoms, such as an abnormal heartbeat, breath, and chest pain. It has been reported that myocarditis has commonly resulted from viral infections, bacterial infections, autoimmune disorders, and toxins. Several circulating autoantibodies induced by infections have been demonstrated and they may play a crucial role in the progression and induction of myocarditis. Studies reported that ASAs (particularly anti-myolemma antibodies) are identified as a serologic hallmark of inflammatory heart muscle disease and its sequelae. Elevated IgG ASAs derived from the sera show a strong correlation with chronic Chagas myocarditis, which suggested that ASAs might be developed as indicators for myocarditis. References: Maisch B, Drude L, Hengstenberg C, Herzum M, Hufnagel G, Kochsiek K, Schmaltz A, Schönian U, Schwab MD. Are antisarcolemmal (ASAs) and antimyolemmal antibodies (AMLAs) "natural" antibodies? Basic Res Cardiol. 1991;86 Suppl 3:101-14. doi: 10.1007/978-3-662-30769-4_10. PMID: 1664204. Links: https://www.ouh.nhs.uk/immunology/diagnostic-tests/tests-catalogue/cardiac-muscle-antibodies.aspx https://www.the-rheumatologist.org/article/know-your-labs/?singlepage=1

Evaluate for adrenal insufficiency and Addison disease.

Evaluate suspected autoimmune rheumatic diseases

Aromatic L-amino acid decarboxylase (AADC) enzyme plays a crucial role in the human body's ability to process certain amino acids into neurotransmitters, which are chemical messengers that transmit signals in the brain and other areas of the nervous system. AADC acts on L-amino acids, particularly those with an aromatic side chain, such as L-dopa (levodopa), converting them into dopamine, and 5-hydroxytryptophan into serotonin. These neurotransmitters are essential for regulating mood, movement, and autonomic functions within the body. The assessment of AADC enzyme activity can help diagnose AADC deficiency—a rare but serious condition that affects neurotransmitter synthesis, leading to developmental delays, movement disorders, and autonomic dysfunction. By evaluating this marker, healthcare providers can gain insights into a patient's neurotransmitter production capabilities, guiding diagnosis and treatment strategies for conditions influenced by neurotransmitter levels. This makes the Aromatic L-amino acid decarboxylase enzyme a significant point of interest for researchers and clinicians alike, offering a window into the complex interplay of genetics, enzyme activity, and neurological health.

detects lung fungus in immune-compromised patients, aiding prompt treatment.

used to detect antibodies due to infection of the tick-borne protozoa Babesia duncani

is a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon.

Cold agglutinins are autoantibodies produced by a person’s immune system that mistakenly target red blood cells (RBCs). They cause RBCs to clump together when a person is exposed to cold temperatures and increase the likelihood that the affected RBCs will be destroyed by the body. This test detects and measures the amount of cold agglutinins in the blood. When the presence of cold agglutinins in a person’s blood leads to significant RBC destruction, it can cause hemolytic anemia and lead to a low RBC count and hemoglobin. This rare form of autoimmune hemolytic anemia is known as cold agglutinin disease. Cold agglutinin disease may be primary or secondary, induced by some other disease or condition. Primary cold agglutinin disease typically affects those who are middle age to elderly, and it tends to continue over time (chronic). Secondary cold agglutinin disease may affect anyone and may be acute or chronic, temporary or persistent. It may cause hemolytic anemia to a greater or lesser degree and is associated with a variety of conditions. The cold agglutinin test is not routinely ordered. It is a test that has been available for a long time, but it has become less commonly used as more specific tests for secondary causes, such as Mycoplasma pneumoniae infection, have become available.

Cytoplasmic Reticular (Mitochondrial) Pattern (Cyto. Reticular MITO) in Immunofluorescence Testing The Cytoplasmic Reticular (MITO) pattern is an immunofluorescence staining pattern observed in indirect immunofluorescence assays (IFA), particularly in Antinuclear Antibody (ANA) testing. This pattern indicates the presence of autoantibodies targeting mitochondrial structures, leading to a distinct reticular (net-like) cytoplasmic fluorescence. Key Features of the Cytoplasmic Reticular (MITO) Pattern Mitochondrial Localization This pattern is associated with autoantibodies binding to mitochondrial proteins, often seen in Primary Biliary Cholangitis (PBC) and other autoimmune liver diseases. Immunofluorescence Appearance The staining appears as a fine, net-like (reticular) fluorescence across the cytoplasm, reflecting the distribution of mitochondria within cells. Associated Autoantibodies Anti-Mitochondrial Antibodies (AMA), particularly the AMA-M2 subtype, are strongly linked to this pattern. AMA-M2 targets components of the pyruvate dehydrogenase complex (PDC-E2) in the inner mitochondrial membrane. Clinical Associations The Cytoplasmic Reticular (MITO) pattern is most commonly associated with: Primary Biliary Cholangitis (PBC) – A chronic autoimmune liver disease affecting intrahepatic bile ducts. Autoimmune Hepatitis (AIH) – Occasionally present in overlap syndromes with PBC. Systemic Autoimmune Diseases – Rarely seen in connective tissue diseases or chronic infections. Diagnostic Considerations Positive Cytoplasmic Reticular (MITO) pattern in an ANA test should prompt further evaluation, including: Anti-Mitochondrial Antibody (AMA) testing Liver function tests (LFTs) Additional autoimmune markers Since ANA testing primarily detects nuclear antibodies, a cytoplasmic staining pattern suggests the need for broader autoimmune screening to confirm clinical significance. Conclusion A Cytoplasmic Reticular (MITO) pattern in immunofluorescence testing is a significant finding, often indicating anti-mitochondrial antibodies (AMA) and associated with autoimmune liver disease, particularly PBC. Further clinical and laboratory evaluation is essential to determine its diagnostic relevance.

Thymidine and Deoxyuridine Analytes

Quantitation of alcohol level for medical or legal purposes

F078-IgE Casein: Understanding Your Lab Results F078-IgE Casein is an allergy test that measures IgE antibodies specific to casein, a protein found in cow’s milk. This test helps identify whether your immune system is triggering an IgE-mediated allergic reaction to casein, which can cause symptoms ranging from mild discomfort to severe allergic responses. What Does an Elevated F078-IgE Casein Level Mean? If F078-IgE Casein is elevated, it indicates a casein allergy, meaning your immune system identifies casein as a harmful substance and releases histamine and other inflammatory chemicals in response. People with a casein allergy may experience: Digestive issues – Bloating, diarrhea, nausea, vomiting Skin reactions – Hives, eczema, itching Respiratory symptoms – Nasal congestion, wheezing, asthma-like symptoms Anaphylaxis (severe cases) – Difficulty breathing, swelling, or a life-threatening reaction This test is particularly useful for diagnosing cow’s milk allergy (CMA), which is different from lactose intolerance (an inability to digest lactose due to enzyme deficiency rather than an immune response). Possible Causes of a Casein Allergy - Genetic predisposition – A family history of food allergies increases the risk. - Immune system hypersensitivity – Overreaction to casein proteins leads to the release of IgE antibodies. - Leaky gut & immune dysfunction – Increased intestinal permeability can expose the immune system to undigested proteins, triggering an allergic response. What Does a Low or Normal F078-IgE Casein Level Mean? No significant immune reaction to casein Less likely to have a true IgE-mediated casein allergy If symptoms persist, non-IgE-mediated dairy sensitivity (e.g., casein intolerance) or other conditions like lactose intolerance should be considered. Managing a Casein Allergy - Eliminate dairy products – Avoid milk, cheese, yogurt, butter, and foods containing casein. - Check ingredient labels – Look for casein derivatives like sodium caseinate or milk solids. - Find dairy alternatives – Opt for plant-based milks (almond, oat, coconut, soy) if tolerated. - Consult an allergist – Further testing, such as a skin prick test or oral food challenge, may be needed for confirmation.

major allergen in milk and the main protein constituent in cheese

F079-IgE Gluten: Understanding Your Lab Results F079-IgE Gluten is an allergy test that measures IgE antibodies specific to gluten, a protein found in wheat, barley, and rye. This test helps determine whether your immune system is producing an IgE-mediated allergic response to gluten, which can lead to symptoms of wheat allergy rather than non-IgE gluten-related conditions like celiac disease or gluten sensitivity. What Does an Elevated F079-IgE Gluten Result Mean? A high F079-IgE Gluten result suggests that your immune system identifies gluten as a harmful substance, triggering an allergic reaction. This may indicate a wheat allergy, where exposure to gluten-containing foods leads to an immediate or delayed allergic response. Symptoms can range from mild to severe and may include: Skin reactions such as hives, itching, or eczema Digestive issues like nausea, vomiting, or abdominal pain Respiratory symptoms such as sneezing, congestion, wheezing, or difficulty breathing Anaphylaxis in severe cases, which is a life-threatening reaction requiring immediate medical attention Unlike celiac disease, which is an autoimmune condition, wheat allergy is an IgE-mediated immune response that can cause immediate hypersensitivity reactions. What Does a Low or Negative F079-IgE Gluten Result Mean? A negative result indicates that you are unlikely to have an IgE-mediated gluten allergy. However, it does not rule out other gluten-related conditions, including: Celiac disease, which involves an autoimmune reaction to gluten but does not involve IgE antibodies. Non-celiac gluten sensitivity (NCGS), which can cause digestive discomfort, fatigue, and neurological symptoms but does not trigger an IgE immune response. Next Steps if Your F079-IgE Gluten Result Is Elevated If you have a high gluten IgE level, you may need to: Avoid gluten-containing foods to prevent allergic reactions. Consult an allergist for further testing, such as a skin prick test or an oral food challenge, to confirm a wheat allergy. Differentiate between wheat allergy, celiac disease, and gluten sensitivity by undergoing additional tests, such as tTG-IgA or an intestinal biopsy for celiac disease.

Immunoglobulin G (IgG) antibodies to specific allergens have not been proved to be involved in pathogenesis of disease. The presence of IgG against otherwise innocuous antigens (such as foods) in serum simply indicates that the individual has been exposed to antigens that are recognized as foreign entities by the immune system. The presence of food-specific IgG alone cannot be taken as evidence of allergy or autoimmune disease and only indicates immunologicsensitization by the food in question. Consequently, thequantitative IgG test should only be ordered by specialists who recognize the limitations of the test. What is wheat and gluten? Wheat is the most widely consumed food grain in the world. The wheat kernel contains approximately 8-15% protein content of which 85%–90% is gluten. Gluten is made up of insoluble gliadins as well as high and low molecular weight glutenins, which are responsible for IgE-mediated reactions in wheat allergy, affecting an estimated 0.4% of the world’s population. Symptoms of wheat allergy usually develop within minutes to hours after ingestion and affect the GI tract (vomiting, colic, diarrhea), skin (urticaria, eczema), respiratory tract (upper respiratory, asthma), or include systemic anaphylactic reactions. Symptoms can also manifest as baker’s asthma (from inhaled flour), atopic dermatitis (from skin exposure), urticaria (forming hives after skin exposure), or wheat-dependent exercise-induced anaphylaxis). Gluten can be found in many other food types, including processed meat, reconstituted seafood, vegetarian meat substitutes, candies, ice cream, butter, seasonings, stuffings, marinades and dressings, as well as coatings in medications and confectionary. Proteins similar to gliadin in wheat are found in other grains, existing as secalin in rye, hordein in barley, and avenins in oats, where they are collectively referred to as “gluten.” Additionally, the derivatives of these grains such as triticale and malt also contain gluten. The gluten found in all of these grains has been identified as the component capable of triggering the immune-mediated disorder, celiac disease. The albumin/globulin protein group in wheat is mostly responsible for allergic reactions including wheat allergy and occupational Baker’s asthma/rhinitis. Wheat allergic subjects can also be sensitized to high and low molecular weight glutenins. The (omega-5) gliadin fraction of gluten is the most common allergen implicated in food-dependent, exercise-induced anaphylaxis.

measuring oxidative stress

Increases in neutral fat are commonly associated with pancreatic exocrine insufficiency.

Increase in stool total fats (neutral fats, soaps, and fatty acids) is likely to be associated with small bowel disease.

to help diagnose a G6PD deficiency

often related to an allergic immune response

Volatile substances in the blood include ethanol, methanol, isopropanol, and acetone. Acetone is generally elevated in metabolic conditions such as diabetic ketoacidosis. Methanol and isopropanol are highly toxic and result from exogenous ingestion. The presence of isopropanol indicates exposure which may result in intoxication and CNS depression. Ingestion of isopropanol can be fatal if patients do not receive immediate medical treatment.

detect possible allergic responses to various substances in the environment

This test measures the level of lactic acid, also known as lactate, in your blood. Lactic acid is a substance made by muscle tissue and by red blood cells, which carry oxygen from your lungs to other parts of your body. Normally, the level of lactic acid in the blood is low. Lactic acid levels rise when oxygen levels decrease. Low oxygen levels may be caused by: - Strenuous exercise - Heart failure - Severe infection - Shock, a dangerous condition that limits blood flow to your organs and tissues If lactic acid levels get too high, it can lead to a life-threatening condition known as lactic acidosis. A lactic acid test can help diagnose lactic acidosis before it causes serious complications. ------------------- Hypoperfusion (=a reduced amount of blood flow) is the most common cause of lactic acidosis and hyperlactacidemia may be the only marker of tissue hypoperfusion. Suspect lactic acidosis when unexplained anion gap metabolic acidosis is encountered, especially if azotemia or ketoacidosis are not present. Evaluate metabolic acidosis, regional or diffuse tissue hypoperfusion, hypoxia, shock, congestive heart failure, dehydration, complicated postoperative state, ketoacidosis or nonketotic acidosis in diabetes mellitus, patients with infections, inflammatory states, postictal state, certain myopathies, acute leukemia and other neoplasia, enzyme defects, glycogen storage disease (type I), thiamine deficiency, and hepatic failure. A spontaneous form of lactic acidosis occurs. It is a prognostic index in particular clinical settings, especially in critically ill patients in shock. A relationship to renal disease also exists. With skin rash, seizures, alopecia, ataxia, keratoconjunctivitis, and lactic acidosis in children, consider defective biotin metabolism. Phenformin, ethanol, methanol, and salicylate poisoning and ethylene glycol may cause lactic acidosis. Acetaminophen toxicity causes lactic acidosis, sometimes with hypoglycemia. Cyanide, isoniazid, and propylene glycol are among the causes of lactic acidosis. Lactic acidosis may be due to inborn errors of metabolism. Creatinine is higher in ketoacidosis than in lactic acidosis, by interference produced by acetoacetic acid on creatinine. Additional notes: The measurement of lactate levels may be indicated in the clinical setting of metabolic acidosis. Serum salicylate, ethanol level, and osmolality may be helpful. Spontaneous lactic acidosis may be fatal. High CSF lactate levels suggest the meningitis is bacterial while low values suggest a viral cause. References: - Schuster HP. Prognostic value of blood lactate in critically ill patients. Resuscitation. 1984; 11(3-4):141-146 (review). PubMed 6326218 - Thoene J, Baker H, Yoshino M, et al. Biotin-responsive carboxylase deficiency associated with subnormal plasma and urinary biotin. N Engl J Med. 1981; 304(14):817-820. PubMed 6782477 - Henning RJ, Weil MH, Weiner F. Blood lactate as a prognostic indicator of survival in patients with acute myocardial infarction. Circ Shock. 1982; 9(3):307-315. PubMed 7094222 - Bailey EM, Domenico P, Cunha BA. Bacterial or viral meningitis? Measuring lactate in CSF can help you know quickly. Postgrad Med. 1990; 88(5):217-219, 223 (review). PubMed 2216980 Anderson CT Jr, Westgard JO, Schlimgen K, et al. Contribution of arterial blood lactate measurement to the care of critically ill patients. Am J Clin Pathol. 1977; 68(1):63-67. PubMed 17295

an anticonvulsant medication commonly used for the treatment of epilepsy and bipolar disorder

anti-inflammatory, regulatory hormone made in the hypothalamus

Detecting methanol in cases of accidental ingestion, or intentional ingestion by potential suicide victims or alcoholics. The presence of methanol indicates exposure which may result in intoxication, central nervous system (CNS) depression, and metabolic acidosis. Ingestion of methanol can be fatal if patients do not receive immediate medical treatment.

most frequently caused by infection with the Epstein-Barr virus (EBV)

to monitor bone formation and antiresorptive therapies

to detect protein C deficiency

Protein S is a critical component of the body's anticoagulation system, playing a pivotal role in regulating blood clot formation. It is a glycoprotein that circulates in the bloodstream and acts as a cofactor for protein C, another important anticoagulant protein. The primary function of protein S is to enhance the activity of activated protein C (APC) in breaking down coagulation factors Va and VIIIa, thus inhibiting the formation of excessive blood clots. This anticoagulant mechanism helps maintain the delicate balance between clot formation and clot dissolution, preventing abnormal or excessive clotting, which can lead to conditions like deep vein thrombosis (DVT), pulmonary embolism (PE), or even stroke. Genetic mutations or deficiencies in protein S can lead to an increased risk of thrombotic events, as the body's ability to regulate blood clotting is compromised. Therefore, measuring protein S activity is a crucial diagnostic tool in assessing an individual's thrombotic risk, and its deficiency often requires lifelong anticoagulant therapy to prevent clot-related complications. Understanding and managing protein S activity is essential in the field of hematology and thrombosis research and clinical practice.

an immunosuppressant drug

Aid in the diagnosis of Strongyloides infection.

Testosterone Free and Weakly Bound

Thymidine and Deoxyuridine Analytes

Thymidine Phosphorylase Activity refers to the measurement of the enzyme's activity in the body, which plays a significant role in nucleotide metabolism—the process by which cells manage their energy and the synthesis of the building blocks of DNA and RNA. Thymidine Phosphorylase (TP) is involved in the breakdown of thymidine, a nucleoside that is a component of DNA, into thymine and deoxyribose-1-phosphate. This process is crucial for the proper recycling of nucleotides and maintaining the balance of DNA synthesis and repair mechanisms within cells. In clinical contexts, the activity of TP can be significant for several reasons. Elevated levels of TP activity have been associated with certain pathological conditions, including various types of cancer, where the enzyme might promote tumor growth and metastasis by enhancing the availability of thymidine for rapid cell division and by other mechanisms, including angiogenesis, the formation of new blood vessels to supply tumors with nutrients. Therefore, measuring Thymidine Phosphorylase Activity can provide valuable insights into the metabolic state of the body and the potential presence of disease processes, aiding in the diagnosis, monitoring, and therapeutic planning for patients with certain cancers or other conditions where TP activity is altered.

Determining whether you had previous exposure to or recent infection with Toxoplasma gondii

an alternative drug in the treatment of complex partial seizures

a key metabolic byproduct found in urine

a hormone found in the pancreas, intestine, and central nervous system

Zinc Transporter 8 Autoantibodies

Zonisamide (Zonegran), Serum – Biomarker Explanation What is Zonisamide? Zonisamide is an anticonvulsant medication primarily used to treat epilepsy and sometimes prescribed off-label for migraine prevention, neuropathic pain, and weight management. It works by stabilizing neuronal activity through sodium and calcium channel modulation, as well as by influencing GABAergic and dopaminergic systems. Why is the Serum Zonisamide Test Important? This test measures the concentration of zonisamide in the blood to ensure it is within the therapeutic range. Monitoring serum levels is critical because: Too Low: The drug may be ineffective at preventing seizures. Too High: Increases the risk of side effects, including dizziness, drowsiness, kidney stones, and metabolic acidosis. Clinical Applications Doctors order this test for: - Assessing drug effectiveness in epilepsy management. - Detecting non-adherence (missed doses or poor absorption). - Preventing toxicity in patients at risk. - Adjusting dosages in those with kidney or liver impairment. Reference Ranges The therapeutic range for zonisamide varies but is generally 10–40 mcg/mL. Levels outside this range may require dosage adjustments. Factors Affecting Zonisamide Levels Dosage and frequency Kidney function (zonisamide is excreted renally) Drug interactions (e.g., phenytoin, carbamazepine, and valproate may lower levels) Liver metabolism efficiency Hydration status (affects clearance and potential for kidney stones) Symptoms of Zonisamide Toxicity Confusion, memory problems Fatigue, dizziness, coordination issues Nausea, loss of appetite Metabolic acidosis (excess acid buildup in the blood) Final Thoughts Regular serum zonisamide monitoring helps ensure optimal seizure control while minimizing side effects. If your levels are outside the normal range, consult your doctor to adjust your dose or assess potential drug interactions.